terminology and guidelines for glaucoma ii - Kwaliteitskoepel
terminology and guidelines for glaucoma ii - Kwaliteitskoepel
terminology and guidelines for glaucoma ii - Kwaliteitskoepel
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
3.6.2 - NON PENETRATING GLAUCOMA SURGERY<br />
These techniques have recently been advocated as operations <strong>for</strong> primary open-angle <strong>glaucoma</strong>. Two different modifications<br />
are presently used as “non-penetrating” surgery 106-111 .<br />
3.6.2.1 - Deep sclerectomy 111-123<br />
In this technique, a deep lamella of corneosclera underneath the scleral flap is excised thus removing the outer wall<br />
of Schlemm’s canal. The outer layer of the inner wall of Schlemm’s canal is frequently also removed. Percolation of<br />
aqueous occurs through the porosity of the remaining trabecular meshwork, possibly through microper<strong>for</strong>ations.<br />
When the scleral flap is repositioned, a “scleral lake” is created. A collagen implant or a hyaluronic acid device is<br />
often used to keep this scleral lake patent. Usually a filtration bleb <strong>for</strong>ms; long-term IOP control was reported to be<br />
less effective than with trabeculectomy 129 .<br />
3.6.2.2 - Viscocanalostomy<br />
In this technique hyaluronic acid is injected into Schlemm’s canal. The mechanism claimed to increase the outflow is<br />
the widening of Schlemm’s canal <strong>and</strong> of the collector channels as well as diffusion of aqueous from the “scleral<br />
lake” 124-130 .<br />
3.6.3 - METHODS OF PREVENTING FILTERING BLEB SCARRING<br />
3.6.3.1 - Antimetabolites<br />
(See also Ch. 3.7 <strong>and</strong> FC XIII)<br />
Antimetabolites such as 5-Fluorouracil (5-FU) <strong>and</strong> Mitomycin-C (MMC) are now used frequently in patients undergoing<br />
<strong>glaucoma</strong> filtration surgery in order to reduce scarring <strong>and</strong> improve drainage. The use of these substances is<br />
being refined, following the outcome of several studies. Indications <strong>and</strong> technique needs to be carefully adhered<br />
to 131 . Risk factors <strong>for</strong> scarring include previous ocular surgery, long-term topical medications particularly those that<br />
cause a red eye 35,132 , young age, black race, uveitis, neovascular <strong>glaucoma</strong> <strong>and</strong> others. The risk of corneal epithelial<br />
erosions, epitheliopathy, late hypotony, bleb leaks <strong>and</strong> bleb infections must be considered. New compounds are<br />
being investigated to more specifically target the biological processes causing excessive scarring, with the aim of<br />
reducing complications 133 .<br />
3.6.3.2 - Alternative methods of preventing filtering bleb scarring<br />
Irradiation<br />
Irradiation by various types of radiation was used during the 1970s <strong>and</strong> has proven to be effective. However, longterm<br />
effects on the lens <strong>and</strong> on the retinal vessels (radiation retinopathy) have to be considered.<br />
Photodynamic therapy<br />
A dye is injected subconjunctivally at the site of operation, resulting in incorporation of the dye into the fibroblasts<br />
of the filtering bleb area. A blue light is then irradiated that will selectively destroy the fibroblasts.<br />
Inhibition of growth factors<br />
Recently, attention has been turned to the role of cytokines in the process of wound healing. TGFß2 has been identified<br />
as a probable key cytokine in post trabeculectomy wound healing. Human monoclonal anti-TGFß2 antibodies<br />
are being tested <strong>and</strong> pilot studies have shown promising results 133 . Other approaches are also considered such as<br />
TGFß2 anti-sense nucleotides, suramine <strong>and</strong> others.<br />
Ch. 3 - 35 EGS